Literature DB >> 24158671

Glyoxalase 1 is up-regulated in hepatocellular carcinoma and is essential for HCC cell proliferation.

Xiaohui Hu1, Xianmei Yang, Quanze He, Qi Chen, Long Yu.   

Abstract

Glyoxalase 1 (Glo1), belonging to the glyoxalase system, participates in the detoxification of methylglyoxal (MG), a byproduct of glycolysis. Glo1 is associated with the progression of many human malignancies. However, the role of Glo1 in hepatocellular carcinoma (HCC) is unclear. We have discovered that the expression of Glo1 is up-regulated in HCC tissues compared with adjacent non-tumorous tissues, and knockdown of Glo1 expression by RNA interference significantly inhibited the proliferation of human HCC cell lines. Glo1 knockdown resulted in the accumulation of its cytotoxic substrate, MG. Overall, thus Glo1 might be essential for HCC progression and can be designated as a potential therapeutic target for HCC in the future.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24158671     DOI: 10.1007/s10529-013-1372-6

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  15 in total

1.  Effects of methylglyoxal and glyoxalase I inhibition on breast cancer cells proliferation, invasion, and apoptosis through modulation of MAPKs, MMP9, and Bcl-2.

Authors:  Yi Guo; Yuning Zhang; Xunjun Yang; Panpan Lu; Xijuan Yan; Fanglan Xiao; Huaibin Zhou; Chaowei Wen; Mengru Shi; Jianxin Lu; Qing H Meng
Journal:  Cancer Biol Ther       Date:  2015-11-30       Impact factor: 4.742

2.  Glo1 genetic amplification as a potential therapeutic target in hepatocellular carcinoma.

Authors:  Shirong Zhang; Xiaodong Liang; Xiaoliang Zheng; Haixiu Huang; Xufeng Chen; Kan Wu; Bing Wang; Shenglin Ma
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

3.  Potent apoptosis-inducing activity of erypoegin K, an isoflavone isolated from Erythrina poeppigiana, against human leukemia HL-60 cells.

Authors:  Kiyomi Hikita; Natsuki Hattori; Aya Takeda; Yuko Yamakage; Rina Shibata; Saori Yamada; Kuniki Kato; Tomiyasu Murata; Hitoshi Tanaka; Norio Kaneda
Journal:  J Nat Med       Date:  2017-11-18       Impact factor: 2.343

4.  Hormetic potential of methylglyoxal, a side-product of glycolysis, in switching tumours from growth to death.

Authors:  Marie-Julie Nokin; Florence Durieux; Justine Bellier; Olivier Peulen; Koji Uchida; David A Spiegel; James R Cochrane; Craig A Hutton; Vincent Castronovo; Akeila Bellahcène
Journal:  Sci Rep       Date:  2017-09-15       Impact factor: 4.379

5.  Glyoxalase 1 expression is associated with an unfavorable prognosis of oropharyngeal squamous cell carcinoma.

Authors:  Nele Kreycy; Christiane Gotzian; Thomas Fleming; Christa Flechtenmacher; Niels Grabe; Peter Plinkert; Jochen Hess; Karim Zaoui
Journal:  BMC Cancer       Date:  2017-05-26       Impact factor: 4.430

6.  Glyoxalase-1 Overexpression Reverses Defective Proangiogenic Function of Diabetic Adipose-Derived Stem Cells in Streptozotocin-Induced Diabetic Mice Model of Critical Limb Ischemia.

Authors:  Zhiyou Peng; Xinrui Yang; Jinbao Qin; Kaichuang Ye; Xin Wang; Huihua Shi; Mier Jiang; Xiaobing Liu; Xinwu Lu
Journal:  Stem Cells Transl Med       Date:  2016-08-15       Impact factor: 6.940

7.  Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2.

Authors:  Yuan Chen; Lei Fang; Jiali Zhang; Gefei Li; Mengni Ma; Changxi Li; Jianxin Lyu; Qing H Meng
Journal:  Int J Mol Sci       Date:  2017-03-09       Impact factor: 5.923

8.  DAPT suppresses proliferation and migration of hepatocellular carcinoma by regulating the extracellular matrix and inhibiting the Hes1/PTEN/AKT/mTOR signaling pathway.

Authors:  Kaijie Qiu; Chenyang Ma; Lingchao Lu; Jie Wang; Baiwen Chen; Haixiang Mao; Yanmin Wang; Haibiao Wang
Journal:  J Gastrointest Oncol       Date:  2021-06

Review 9.  The Role of Glyoxalase-I (Glo-I), Advanced Glycation Endproducts (AGEs), and Their Receptor (RAGE) in Chronic Liver Disease and Hepatocellular Carcinoma (HCC).

Authors:  Marcus Hollenbach
Journal:  Int J Mol Sci       Date:  2017-11-20       Impact factor: 5.923

10.  Synergistic inhibition of colon cancer growth by the combination of methylglyoxal and silencing of glyoxalase I mediated by the STAT1 pathway.

Authors:  Yuan Chen; Lei Fang; Gefei Li; Jiali Zhang; Changxi Li; Mengni Ma; Chen Guan; Fumao Bai; Jianxin Lyu; Qing H Meng
Journal:  Oncotarget       Date:  2017-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.